Health & Life Co., Ltd. (TPEX:1781)
12.05
-0.05 (-0.41%)
Jan 22, 2026, 1:30 PM CST
Health & Life Revenue
Health & Life had revenue of 89.56M TWD in the quarter ending September 30, 2025, a decrease of -60.49%. This brings the company's revenue in the last twelve months to 441.84M, down -33.17% year-over-year. In the year 2024, Health & Life had annual revenue of 706.39M with 17.50% growth.
Revenue (ttm)
441.84M
Revenue Growth
-33.17%
P/S Ratio
1.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
571.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 706.39M | 105.22M | 17.50% |
| Dec 31, 2023 | 601.17M | -196.37M | -24.62% |
| Dec 31, 2022 | 797.54M | -14.34M | -1.77% |
| Dec 31, 2021 | 811.88M | 37.72M | 4.87% |
| Dec 31, 2020 | 774.16M | 352.99M | 83.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |
| Caliway Biopharmaceuticals | 34.99M |